Home

Steven L. Hoerter

CIK 1533451 · President and CEO · last filed 2026-06-26

Steven L. Hoerter is a President and CEO who has filed 73 SEC Form 4 insider transactions across 8 companies since 2012. The most recent filing, for CCCC, was dated Jun 26, 2026. Across all open-market trades the lifetime net is −$9.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.3M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.31M

Companies

8

Total Filings

73

Lifetime Open-Market Net

-$9.16M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CCCC Director — $3.55 — $0 3 2026-06-26
MBX Director 31,938 $60.06 $1.92M $265.0K 9 2026-06-05
ORIC Director — $11.91 — $0 6 2026-01-06
Deciphera Pharmaceuticals, Inc. (DCPH) Delisted President and CEO 72,763 $25.59 $1.86M -$1.33M 21 2024-06-11
CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted Director — $33.99 — $0 4 2021-06-04
AGIO Chief Commercial Officer 10,941 $35.99 $393.8K -$3.75M 16 2019-03-05
Ignyta, Inc. (RXDX) Delisted Director — $199.92 — $0 2 2017-06-19
Clovis Oncology, Inc. (CLVS) Delisted See Remarks 0 $0.08 $0 -$4.34M 9 2015-03-09

Recent Filings

73 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-26 CCCC Grant (A) — $0 EDGAR
2026-06-05 MBX Grant (A) — $0 EDGAR
2026-05-04 MBX Grant (A) +11,938 $0 EDGAR
2026-04-22 MBX Grant (A) — $0 EDGAR
2026-04-22 MBX Grant (A) — $0 EDGAR
2026-01-06 ORIC Grant (A) — $0 EDGAR
2025-11-25 MBX Grant (A) — $0 EDGAR
2025-11-07 MBX Grant (A) — $0 EDGAR
2025-10-20 MBX Buy (P) +20,000 $265.0K EDGAR
2025-06-20 CCCC Grant (A) — $0 EDGAR
Showing 1–10 of 73
Page 1 of 8
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.